Blood
AML with mutated TP53, therapy-related, with basophilic differentiation, partial CD22, and ring sideroblasts.
Zhaodong Xu, Eric McGinnis
Published: 202510.1182/blood.2025029483
No abstract available for this study.
Zhaodong Xu, Eric McGinnis
No abstract available for this study.